NCT07436312
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +29 more
- Locations
-
- Institut Sainte Catherine Avignon, France
- Eugène Marquis Rennes, France
- Gustave Roussy Villejuif, France
Clinical trial condition
Germline BRCA2 Gene Mutation
Explore clinical trials studying Germline BRCA2 Gene Mutation. Study availability and eligibility vary by location and protocol.
4 public trials
2 recruiting studies
Germline BRCA2 Gene Mutation trial results
NCT04090567
- Conditions
- Advanced Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, +18 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Niraparib + Dostarlimab In BRCA Mutated Breast Cancer
NCT04584255
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +11 more
- Locations
-
- Yale University Cancer Center New Haven, Connecticut, United States
- Johns Hopkins University Baltimore, Maryland, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
Active, Not Recruiting
Prospective Study of MAstectomy With Reconstruction Including Robot Endoscopic Surgery
NCT04585074
- Conditions
- Benign Breast Disease, Breast Diseases, Breast Neoplasms, +15 more
- Locations
-
- Kosin University Gospel Hospital Busan, South Korea
- Chungnam National University Sejong Hospital Sejong, Chungcheongnam-do, South Korea
- Kyungpook National University Chilgok Hospital Daegu, South Korea
- Wonju Severance Christian hospital Wŏnju, Gangwon-do, South Korea